PT-141 dosing window - how long before activity for optimal effect
Posted: Wed Mar 18, 2026 12:00 pm
Been using melanotan variants for years. Know the mechanism, MC4R agonism, central not peripheral. Not asking about that.
What I actually can't nail down is the timing. Every source says something different. 30 minutes, 2 hours, 4 hours. The older MT-II literature suggested fairly rapid onset but PT-141 seems to behave differently in practice even though the mechanism is similar.
Running 1mg intranasal currently. Effects are real but timing feels inconsistent. Some sessions the response is almost immediate, other times it's sluggish for over an hour then hits hard.
Is this a variable absorption issue with intranasal vs subQ, or is there something about MC4R receptor saturation state that affects onset time? Wondering if dosing consistency matters here, meaning does receptor downregulation between doses affect the timing or just the magnitude.
Not interested in anecdotal "it worked great for me at X time" responses. Looking for anyone who's done systematic timing comparisons or knows the pharmacokinetic literature well enough to actually address this.
What I actually can't nail down is the timing. Every source says something different. 30 minutes, 2 hours, 4 hours. The older MT-II literature suggested fairly rapid onset but PT-141 seems to behave differently in practice even though the mechanism is similar.
Running 1mg intranasal currently. Effects are real but timing feels inconsistent. Some sessions the response is almost immediate, other times it's sluggish for over an hour then hits hard.
Is this a variable absorption issue with intranasal vs subQ, or is there something about MC4R receptor saturation state that affects onset time? Wondering if dosing consistency matters here, meaning does receptor downregulation between doses affect the timing or just the magnitude.
Not interested in anecdotal "it worked great for me at X time" responses. Looking for anyone who's done systematic timing comparisons or knows the pharmacokinetic literature well enough to actually address this.